FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091871537> ?p ?o ?g. }

• W3091871537 endingPage "30" @default.
• W3091871537 startingPage "23" @default.
• W3091871537 abstract "Abstract Introduction In a previous report, we used canonical correlation analysis to classify individuals with clinical high risk (CHR) of psychosis into the 3 subtypes: subtype-1, characterized by extensive negative symptoms and cognitive deficits, appeared to have the highest risk for conversion to psychosis; subtype-2, characterized by thought and behavioral disorganization, with moderate cognitive impairment; subtype-3, characterized by the mildest symptoms and cognitive deficits. The present study attempted to identify these subtypes’ response to antipsychotic (AP) treatment. Methods A total of 289 individuals with CHR were identified and followed up for 2 years. Individuals with CHR were classified by subtype. Use of APs was examined at 2-month, 1-year, and 2-year follow-up interviews that inquired after the subjects’ medication history since the first visit. The main outcome was remission, determined according to global assessment of function (GAF) score (i. e., functional outcome) and SIPS positive symptom score (symptomatic outcome) at the follow-up points. Results Among the 289 individuals with CHR included in the current analysis, 223 (77.2%) were treated using APs for at least 2 weeks during the follow-up period. Individuals with CHR tended to show significant improvement in both symptoms and function after 2 years, but subtypes exhibited significantly different trajectories. Subtype status can predict AP treatment outcome in terms of remission. The likelihood of remission differed significantly among the subtype groups. The remission rates for individuals with subtypes 1–3 treated using AP were 13.5%, 36.1%, and 67.0%, respectively. Discussion These subtypes may be of clinical value in AP treatment decision-making in the CHR population." @default.
• W3091871537 created "2020-10-15" @default.
• W3091871537 creator A5003728286 @default.
• W3091871537 creator A5012276279 @default.
• W3091871537 creator A5016774224 @default.
• W3091871537 creator A5019444350 @default.
• W3091871537 creator A5031172404 @default.
• W3091871537 creator A5036318674 @default.
• W3091871537 creator A5048989648 @default.
• W3091871537 creator A5054133322 @default.
• W3091871537 creator A5058226962 @default.
• W3091871537 creator A5072024833 @default.
• W3091871537 creator A5084907875 @default.
• W3091871537 date "2020-10-12" @default.
• W3091871537 modified "2023-10-06" @default.
• W3091871537 title "Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission" @default.
• W3091871537 cites W1834366268 @default.
• W3091871537 cites W1967674108 @default.
• W3091871537 cites W1990043440 @default.
• W3091871537 cites W1992097629 @default.
• W3091871537 cites W1999757758 @default.
• W3091871537 cites W2008010615 @default.
• W3091871537 cites W2024654275 @default.
• W3091871537 cites W2037922083 @default.
• W3091871537 cites W2047120106 @default.
• W3091871537 cites W2057883114 @default.
• W3091871537 cites W2065826711 @default.
• W3091871537 cites W2103926490 @default.
• W3091871537 cites W2106894252 @default.
• W3091871537 cites W2107878018 @default.
• W3091871537 cites W2109642345 @default.
• W3091871537 cites W2121366540 @default.
• W3091871537 cites W2128456675 @default.
• W3091871537 cites W2130372506 @default.
• W3091871537 cites W2135392214 @default.
• W3091871537 cites W2146755519 @default.
• W3091871537 cites W2159977744 @default.
• W3091871537 cites W2192825006 @default.
• W3091871537 cites W2346327733 @default.
• W3091871537 cites W2404967015 @default.
• W3091871537 cites W2507950479 @default.
• W3091871537 cites W2522369531 @default.
• W3091871537 cites W2721504914 @default.
• W3091871537 cites W2745379835 @default.
• W3091871537 cites W2750713296 @default.
• W3091871537 cites W2789548121 @default.
• W3091871537 cites W2790797709 @default.
• W3091871537 cites W2794642496 @default.
• W3091871537 cites W2806719971 @default.
• W3091871537 cites W2907557004 @default.
• W3091871537 cites W2940027693 @default.
• W3091871537 cites W2970471631 @default.
• W3091871537 cites W3027409811 @default.
• W3091871537 cites W4293226656 @default.
• W3091871537 doi "https://doi.org/10.1055/a-1252-2942" @default.
• W3091871537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33045753" @default.
• W3091871537 hasPublicationYear "2020" @default.
• W3091871537 type Work @default.
• W3091871537 sameAs 3091871537 @default.
• W3091871537 citedByCount "2" @default.
• W3091871537 countsByYear W30918715372023 @default.
• W3091871537 crossrefType "journal-article" @default.
• W3091871537 hasAuthorship W3091871537A5003728286 @default.
• W3091871537 hasAuthorship W3091871537A5012276279 @default.
• W3091871537 hasAuthorship W3091871537A5016774224 @default.
• W3091871537 hasAuthorship W3091871537A5019444350 @default.
• W3091871537 hasAuthorship W3091871537A5031172404 @default.
• W3091871537 hasAuthorship W3091871537A5036318674 @default.
• W3091871537 hasAuthorship W3091871537A5048989648 @default.
• W3091871537 hasAuthorship W3091871537A5054133322 @default.
• W3091871537 hasAuthorship W3091871537A5058226962 @default.
• W3091871537 hasAuthorship W3091871537A5072024833 @default.
• W3091871537 hasAuthorship W3091871537A5084907875 @default.
• W3091871537 hasConcept C118552586 @default.
• W3091871537 hasConcept C126322002 @default.
• W3091871537 hasConcept C15744967 @default.
• W3091871537 hasConcept C169900460 @default.
• W3091871537 hasConcept C187212893 @default.
• W3091871537 hasConcept C2776412080 @default.
• W3091871537 hasConcept C2779727114 @default.
• W3091871537 hasConcept C2780200951 @default.
• W3091871537 hasConcept C2780494398 @default.
• W3091871537 hasConcept C70410870 @default.
• W3091871537 hasConcept C71924100 @default.
• W3091871537 hasConceptScore W3091871537C118552586 @default.
• W3091871537 hasConceptScore W3091871537C126322002 @default.
• W3091871537 hasConceptScore W3091871537C15744967 @default.
• W3091871537 hasConceptScore W3091871537C169900460 @default.
• W3091871537 hasConceptScore W3091871537C187212893 @default.
• W3091871537 hasConceptScore W3091871537C2776412080 @default.
• W3091871537 hasConceptScore W3091871537C2779727114 @default.
• W3091871537 hasConceptScore W3091871537C2780200951 @default.
• W3091871537 hasConceptScore W3091871537C2780494398 @default.
• W3091871537 hasConceptScore W3091871537C70410870 @default.
• W3091871537 hasConceptScore W3091871537C71924100 @default.
• W3091871537 hasFunder F4320321001 @default.
• W3091871537 hasFunder F4320321885 @default.
• W3091871537 hasFunder F4320330350 @default.

• next